Clinical Group

International Journal of Immunotherapy and Cancer Research

ISSN: 2455-8591

DOI

CC By

Advertise with us
Journal Information
  • Volume/IssueClick here
  • Review ProcessDouble Blind
    • Publication lead time3 - 4 weeks
    • Indexing statusYes; Purview
    • Manuscript Processing ChargesClick here
    • Submission ChargesNo
    • Waiver policy for APCYes
    • Language of Full TextEnglish
    • Full-text formats availablePDF, HTML
  • Show +
Best Practices
  • Type of LicenseCreative Commons
  • Open AccessYes; Policy
    • Does the author retain unrestricted copyright?Yes
    • Does the author retain publishing rights?Yes
    • Permanent article identifierDOI (Digital Object Identifier)
  • Show +
Publisher Information

Description

International Journal of Immunotherapy and Cancer Research is a multi-disciplinary peer-reviewed, open access journal. Journal brings together all the varied aspects of research that will ultimately lead to the prevention of cancer. With the goal of advancing technology and improving health care by bringing researchers and practitioners together from academia and industry

Read more

Editor-in-chief

Kwang-Hyun Baek
Kwang-Hyun Baek

CHA University, Republic of Korea

Email: baek@cha.ac.kr
Tel: 82-31-881-7134
Fax: 82-31-881-7134
Skype: khb0529
More Info.

Editorial Board

Monica C Botelho
Head
Head, Department of Health Promotion and Chronicle Diseases
University of Porto
Portugal
monicabotelho@hotmail.com
IJICR

Research Interest: Molecular carcinogenesis of schistosome associated squamous cell carcinoma of the bladder with mouse experiments as models of carcinogenesis; Effects of schistosoma-derived estrogenic molecules on cell lines and the accumulation and biodistribution of these molecules in animal models, and their possible carcinogenic effect; Schistosomiasis associated catechol-estrogens.


More Info.
Emmanuel Enoch Kwaku
Professor
School of Life Sciences
University of Science and Technology of China
China
deek2083@yahoo.co.uk
IJICR

Research Interest: RNA interefence, Immunotherapy and Immunodiagnostics

More Info.
LV Rao
Professor
Department of Clinical Pathology
UMass Memorial Health Care
USA
Lokinendi.Rao@umassmemorial.org
IJICR

Research Interest: Lab Medicine, Clinical Chemistry, Endocrinology and Immunology.

More Info.
Romeo-Gabriel Mihaila
Professor
Faculty of Medicine of Lucian Blaga
University of Sibiu, Romania
Romania
romeomihaila@yahoo.com
IJICR

Research Interest: Leukemia and lymphoma – clinical aspects,  Adjuvant treatments in malignant hemopathies (e.g. resveratrol, statins), Connections between malignant hemopathies and dyslipidemia or metabolic syndrome, Thrombin generation in malignant hemopathies

More Info.
Jesus M Paramio
Researcher
Biomedical Research Institute
University Autonoma
Spain
jesusm.paramio@ciemat.es
IJICR

Research Interest: Malignant transformation, including DNA Repair mechanisms, roles of Cytoskeleton in signal transduction, Developmental processes

More Info.
Maria Filomena Rabaca Roque Botelho
Professor
Faculty of Medicine
Coimbra University
Portugal
mfbotelho@fmed.uc.pt
IJICR

Research Interest: Biophysics; Development of animal models for human diseases (cancer, cardiac ischemia); Nuclear Oncology (from molecular biology to molecular imaging); Photodynamic therapy in models in vitro and in vivo; Radiopharmacy.

More Info.
Barbara Wollenberg
Professor
Department of Otorhinolaryngology
Universitatsklinikum Schleswig-Holstein
Germany
Barbara.Wollenberg@uksh.de
IJICR

Research Interest: Head and neck oncology, molecular as well as clinically molecular rhinology

More Info.
Steve A Maxwell
Associate Professor
Department of Molecular and Cellular Medicine
Texas A&M Health Science Center
USA
smaxwell@medicine.tamhsc.edu
IJICR

Research Interest: Cancer Genetics, Apoptosis, Oncogenes, Tumor Suppressor Genes, Mechanisms of Anti-Cancer Drug Resistance.

More Info.
Arun Seth
Professor
Laboratory Medicine and Pathobiology
University of Toronto
Canada
arun.seth@utoronto.ca
IJICR

Research Interest:

1. Development of mouse models for understanding and treating cancer

2. Understanding of therapies that target immune checkpoints.

3. Tumor Biomarkers: MicroRNA signature predictive of prostate cancer recurrence and metastasis 

4. Clinical Genomics: Application of genomics data in a clinical setting

More Info.
Constantinos Giaginis
Assistant Professor
Department of Food Science & Nutrition
University of Aegean
Greece
cgiaginis@yahoo.gr
IJICR

Research Interest: Research areas of human physiology and pathophysiology. His research focuses on the clinical evaluation of new biomarkers and molecular mediators in several pathophysiological disease states, such as diabetes, atherosclerosis and cancer. His research interest also includes the development of quantitative structure-activity relationships (QSARs) and quantitative structure-property relationships (QSPRs) in the area of toxicology and pharmacology. Furthermore, his research interest lies in the assessment of physicochemical properties, such as lipophilicity, solubility and ionization of drugs, natural bioactive compounds and toxic chemicals in relation with their potential biological activity and toxicity endpoints, as well as their Absorption/Distribution/Metabolism/Excretion (ADME) parameters and their pharmacokinetic and toxicokinetic profiles

More Info.
Jens Hahne
Scientist
Molecular Pathology
Institute of Cancer Research
UK
hahnejen@yahoo.de
IJICR

Research Interest: Tumours Role of transcription factors for angiogenesis, tumour invasion and metastasis Interaction of tumour cells and cells of the tumour stroma Translational research Molecular targeting therapy Biochemical, immunological and pharmacological assays for characterization of the efficacy of different therapeutic agents Tumour immunology Immune evasion mechanism of tumour cells.

More Info.
Wenwen Sha
Assistant Professor
Immunology and Virology
Chinese Academy of Sciences
China
wenwensha@gmail.com
IJICR

Research Interest: Immunology and Virology

More Info.
Monica Rinaldi
Research Scientist
Department of BioMedicine
National Research Council
Italy
monica.rinaldi@ift.cnr.it
IJICR

Research Interest: Development of new DNA vaccines and adjuvants for anticancer therapy and/or prevention, intended for clinical application. Preclinical protocols of genetic immunization against tumor-associated antigens Combined therapeutic protocols (vaccination+immunotherapy+chemotherapy) in preclinical research.

More Info.
Robert John Amato
Professor
Department of Internal Medicine
University of Texas Health Science Center
USA
robert.amato@uth.tmc.edu
IJICR

Research Interest: Oncology, urologic oncology, targeted therapy, cancer genomics and prostate cancer.

More Info.
Rasika Rohatgi
Researcher
Cancer Biology
University of Massachusetts Medical School
USA
rasikarohatgi@gmail.com
IJICR

Research Interest: Molecular mechanisms  and  signaling  pathways  underlying  cancer  progressi on,  metastasis and chem resistance

More Info.
View more

Analysis of Risk Factors for Development of Hepatocellular Carcinoma in Chronic HBV - Infected Liver Cirrhosis Patients: A Meta-Analysis

Published On: August 22, 2017 | Pages: 034 - 040

Author(s): Xiang Lyu, Gaofeng Cai, Kui Liu, Sichao Huang, Jun Yao, Zhenggang Jiang, Zhengting Wang, Zhifang Wang*, Yongdi Chen*, Huakun Lv* and Jianmin Jiang*
View Article DOI: 10.17352/2455-8591.000017

Osteotropism of Breast and Prostate Cancer: Clinical and Experimental Perspective

Published On: May 20, 2017 | Pages: 032 - 033

Author(s): Manuel Scimeca#, Francesca Starace#, Deborah Gratti, Viviana Benedicta Sapia, Rita Bonfi glio and Elena Bonanno*
View Article DOI: 10.17352/2455-8591.000016

Immunomodulatory Effects of Food Additives

Published On: April 17, 2017 | Pages: 019 - 031

Author(s): Hamid Y Dar, Shivani Chaturvedi, Karishma Srivastava, Zaffar Azam, Rajaneesh Anupam, Rajesh K Mondal, Geetanjali B Tomar, Ashish K Singh, Pradyumna K Mishra and Rupesh K Srivastava*
View Article DOI: 10.17352/2455-8591.000015

A Study of Glucosylceramide Synthase and Glycolytic Pathway Enzymes in Patients with Hypereosinophilia

Published On: March 31, 2017 | Pages: 015 - 018

Author(s): Lisa Redmond, Paul Kennedy, Colm Buckley and Philip T Murphy*
View Article DOI: 10.17352/2455-8591.000014

A Very Rare Case of Polycythemia Vera Patient Who Developed Other Four Cancers

Published On: February 03, 2017 | Pages: 012 - 014

Author(s): Romeo-Gabriel Mihaila*
View Article DOI: 10.17352/2455-8591.000013

Immunosuppressive and Cytotoxic Potential of Flavonoids from Medicinal Plants: Preliminary Investigation for Anticancer Activity

Published On: February 01, 2017 | Pages: 007 - 011

Author(s): Amit Gupta* and Revati N Chavan
View Article DOI: 10.17352/2455-8591.000012

Dalton’s Lymphoma as a Murine Model for Understanding the Progression and Development of T-Cell Lymphoma and Its Role in Drug Discovery

Published On: February 01, 2017 | Pages: 001 - 006

Author(s): Raj Kumar Koiri*, Aditi Mehrotra and Surendra Kumar Trigun
View Article DOI: 10.17352/2455-8591.000011

Significance of Cancer Stem Cells in Anti-Cancer Therapies

Published On: December 31, 2016 | Pages: 014 - 016

Author(s): Mónica Botelho* and Helena Alves
View Article DOI: 10.17352/2455-8591.000010

A Synchronous Presentation of AITL with Adenocarcinoma of Lung

Published On: October 06, 2016 | Pages: 011 - 013

Author(s): Kanagaraja Karunakaran Parathan*
View Article DOI: 10.17352/2455-8591.000009

Cytokine Production and Human Cytomegalovirus Load in Allogeneic Hematopoietic Stem Cell Transplantation Outcome

Published On: June 17, 2016 | Pages: 003 - 010

Author(s): TA Silva**, JF Correia-Silva, RG Resende, MHNG Abreu, AL Teixeira, H Bittencourt, RS Gomez
View Article DOI: 10.17352/2455-8591.000008
TOP